Both in Pharmaceuticals
Sunshine Biopharma vs Karyopharm Therapeutics
Over the past year SBFM returned −99.2% and KPTI returned −98.7%; their daily moves had a correlation of 0.01.
SBFM −99.2% KPTI −98.7%Growth of $1, one year, split-adjusted
| Metric | SBFM | KPTI |
|---|---|---|
| Price | $2.65 | $0.0729 |
| Market cap | $2.0M | $1.7M |
| Today | −3.28% | −17.44% |
| 1 month | −66.7% | −88.8% |
| 6 months | −98.8% | −99.2% |
| Year to date | −98.9% | −99.0% |
| 1 year | −99.2% | −98.8% |
| Revenue growth (YoY) | −1.6% | −11.9% |
| Gross margin | 26.2% | 96.8% |
| Net margin | −16.9% | −200.5% |
| P/E (TTM) | — | — |
| Price / sales | 0.1× | 0.0× |
| Net cash | $13.7M | -$184.8M |
| Dividend yield | — | — |
| Volatility (60d) | 896.4% | 413.8% |
| Short % of float | 5.9% | 34.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).